Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion

Similar documents
versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects

Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

15h30 16h00. 16h00 17h30. 17h40 19h Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e

World Health Organization. A Sustainable Health Sector

7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV

EACS HIV Summer School PRELIMINARY PROGRAMME

Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya

Prioritized research questions for adolescent HIV testing, treatment and service delivery

Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

IFMSA Policy Statement Ending AIDS by 2030

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013

HIV Drug Resistance (HIVDR)

Arizona State Office of Rural Health Webinar Series

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Session 1 Basic HIV Facts. Patient Navigation Intervention

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.

WHO WHO AIDS 2018 JOIN US AT

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

Evolving HIV Treatment Paradigms What we need to know

The CQUIN Learning Network. Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Technical guidance for Round 9 Global Fund HIV proposals

THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

HIV Treatment as Prevention (TasP)

Biomedical Prevention Update Thomas C. Quinn, M.D.

HIV Epidemic in India

World Health Organization Strategy for HIV Drug Resistance Surveillance in Low- and Middle- Income Countries

HIV AND INFANT FEEDING

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

Treat All : From Policy to Action - What will it take?

Towards universal access

Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization

INTERNAL QUESTIONS AND ANSWERS DRAFT

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China

HIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center

Diagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar

THE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology

Multiple choice questions: ANSWERS

HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME

UPDATE ON THE CLINICAL MANAGEMENT OF HIV IN BARBADOS

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

Impact of ART resistance in sub Saharan Africa

Clinical Management Guidelines 2012

INTEGRATING HIV INTO PRIMARY CARE

GLOBAL AIDS MONITORING REPORT

HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.

TasP and PrEP- Wishful thinking in the developing world?

Practice Transformation Project Provider Assessment (PT-PA)

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

WESTERN CAPE ART GUIDELINES PRESENTATION 2013

Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

Essential minimum package ALHIV service provision: Community level

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

Day Seven: Helping HIV Affected Children and Orphans

In the Caribbean, the rate of new HIV infections, concentrated among key population, remained stable ART 8

AETC INTERPROFESSIONAL EDUCATION FACULTY BASELINE ASSESSMENT

Technical Guidance Note for Global Fund HIV Proposals. TREATMENT - Antiretroviral Treatment-infants, children and adults

IAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010

Reviewing Sexual Health and HIV NM2715

Objectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Anti Retroviral Traitment (ARVs)

Living Positively with HIV

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES

ARV Consolidated Guidelines 2015

Scaling up priority HIV/AIDS interventions in the health sector

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION

INTRODUCTION AND GUIDING PRINCIPLES

BASIC HEALTH CARE SERVICES Community Health Free Clinic

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

High Impact Prevention: Science, Practice, and the Future of HIV

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences

WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean

Consultation on WHO ART Guidelines

Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts)

TB/HIV Monitoring & Advocacy Project Interview Tool

PRECONCEPTION COUNSELING

World Food Programme (WFP)

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Aligning UNICEF s HIV Vision to the SDGs and UNAIDS Strategy. Dr. Chewe Luo Chief, HIV/AIDS Section UNICEF NYHQ 5 April 2016

increased efficiency. 27, 20

BUDGET AND RESOURCE ALLOCATION MATRIX

Elements of Reproductive Health

Transcription:

CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now pregnant. What to do? - Teen adherence Session 1B Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion Session 1C Skills building - Nurse cases - Cases primary healthcare, rural doctors - Cases nurses - Panel discussion: Integration; Restarting 15h30 16h00 16h00 17h30 17h40 19h00 19h00 21h00 Session 2: Open Session Debate: Undetectable = Untransmittable - Yes - No Session 3: Opening Plenary Official conference opening Mechanism of resistance HIV drug resistance: are we about to win the war? Opening Cocktail Function 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e

THURSDAY, 25 OCTOBER 2018 07h30 08h15 Session 4 Stock outs and medicine availability - Stop Stockouts Project - Essential medicines to add to the formulary - TB 08h30 10h00 Session 5: Plenary Session 90-90-90 - How are we doing with HIV self-testing? - How are we doing with Universal test and treat? - How are we doing with retention and viral suppression? - How are we doing with prevention 10h00 10h30 10h30 12h00 12h00 13h30 Session 6A PrEP consult - How to administer PrEP: a typical clinical consultation - How to bill PrEP coding - The experience of a treating physician Lunch, exhibition and posters Session 6B Infant testing - Swallowing tablets - Paediatric third-line - The latest on infant testing, and how to access - Switching in children - Weight and age Session 6C Ethics and the Law - Whistle-blowing in the health-sector - Mandatory testing - Ethics on how health budgets are split - Q&A Satellite Session 7A GlaxoSmithKline session 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 3 P a g e

13h30 15h00 Session 8A Cancer treatment models - Kaposi Sarcoma - Lymphoma - Role of pap smears in the HIV world - Update on cancer treatment Session 8B Resistance - Viral resistance first-line and second-line - At which detectable viral load should we switch? - Third-line treatment. Feedback on outcome of patients on national third-line regimen - Transmitted drug resistance: surveillance, implications, future Session 8C Prevention - Non-biomedical approaches - Condoms - Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches - VMMC - Treatment as prevention - HIV prevention 2020 road map 15h00 15h30 15h30 17h00 Hall 5 Session 9A An update on - Integrase inhibitors - Protease Inhibitors - NRTIs - NNRTIs - Drug-drug interaction Session 9B What s coming / What s missing in paediatrics - Integrase inhibitors - Protease Inhibitors - Drug interactions Session 9C Modelling and scale-up - What are the numbers telling us - How the epidemic informs resource planning Cost effectiveness of TLD versus TEE 17h10 18h40 Session 10A Resistance - Third-line Session 10B Counselling - How to deliver HIV risk reduction counselling in 2018 Session 10C - Basic science 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 4 P a g e

- Stanford database - how to interpret resistance test results - Integrating HIV prevention with other services 18h50 20h20 Session 11: Debate (Open Session) Hall 4 Implications of scarcer resources for 90:90:90 - Panel discussion FRIDAY, 26 OCTOBER 2018 07h30 08h15 Southern African HIV Clinicians Society AGM 08h30 10h00 Session 12: Plenary Our current understanding of antibodies Why do we need cure How do you measure cure Management of patients with advanced HIV 10h00 10h30 10h30 12h00 Session 13A Opportunistic infections - An approach to intracranial mass lesions in HIV patients - Pneumocystis pneumonia - Endemic mycoses in HIV patients - An approach to chronic diarrhoea Session 13B HIV and TB in children and adults - Paediatric TB diagnosis and management - TB in children and HIV-TB coinfection - TB in adults and HIV-TB coinfection - TB and HIV co-infection including IRIS Session 13C Key populations and mobile populations - Injecting drug users in the region - Sex workers including satellite clinics; peer support - Engaging in care - Testing in taxi ranks 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 5 P a g e

12h00 13h30 13h30 15h00 Lunch, exhibition and posters Session 15: Plenary Botswana DLT success Could good point-of-care testing revolutionise issues in the region? Balancing politicians, ministries of health, communities and donors Satellite Session 14B GILEAD session 15h00 15h30 15h30 17h00 Session 16A Skills building Clinical skills building Session 16B TB - Should the private sector be treating TB? Yes No Session 16C Update on PMTCT - Where are we with PMTCT, including epidemiology - Transmission of HIV in breastfeeding - Pregnant women on ART programmatic issues - Contraception, clinical issues, MPTs and new technologies 17h10 18h40 19h00 22h30 Session 17A DTG in pregnancy and breastfeeding - Safety - Efficacy Session 17B Technology Celebratory Dinner (RSVP only additional fee applies) Session 17C Ethics and research - The informed consent process - Payment of participants and of doctors - Q&A 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 6 P a g e

SATURDAY, 27 OCTOBER 2018 07h30 08h15 Session 18: Meet the Professor / Clinician How did I start my academic / research career? 08h30 10h00 Session 19: Plenary Vaccinations - HPV vaccines - Model for screening - Other vaccines - World of broadly neutralising antibodies - Pregnant women 10h00 10h30 10h30 12h00 12h00 13h30 - Society vaccination guidelines Session 20A Noncommunicable diseases - Inflammation - Hypertension - Obesity - Mental health - HIV and cardiology Lunch, exhibition and posters Session 20B Ethics and technology - Electronic medical records - Digital database and the PoPI act - Biobanks Session 20C Sexually transmitted infections - Strategy new strategy but what are the real implications - Hepatitis C - Update on vaginal microbiome and HIV - In context of PrEP - Management of STIs in HIV+ population case-based Satellite Session 21A Johnson & Johnson session 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 7 P a g e

13h30 15h00 Session 22A Advanced HIV Management - Care of aging patients - Cryptococcal meningitis - Palliative care Session 22B Treatment optimisation Session 22C Best abstracts session Chair: Moeketsi Mathe 15h10 16h40 Session 23A Skills building Guidelines: all new Session 23B Adherence - Adherence - Adherence clubs - Role of viral load testing in adherence Session 23C Quality Improvement c/o the Aurum Institute 16h50 18h15 18h15 18h20 Session 24: Closing Plenary Big challenges in public health Big challenges in TB preventative therapy Big challenges in introducing and scaling up new prevention technologies Conference closing Moeketsi Mathe 2018.05.02 Southern African HIV Clinicians Society Conference 2018 programme subject to change 8 P a g e